We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Preclinical Modeling of Tumor Metastasis and Resistance: Current Challenges and New Approaches

Article   Apr 15, 2019 | by Fiona Nielsen, CEO of Repositive

 
Preclinical Modeling of Tumor Metastasis and Resistance: Current Challenges and New Approaches
 
 
 

RELATED ARTICLES

The Evolving Field of Cancer Biomarkers

Article

Given the complexity of cancer, it’s arguably unlikely that single molecules will work as clinically meaningful biomarkers for cancer. Today, biomarker discovery involves detecting patterns – characteristics or phenotypes that can be measured and monitored throughout a patient’s journey. Here, we look at two approaches being explored in this evolving field.

READ MORE

Sensitivity vs Specificity

Article

When developing diagnostic tests or evaluating results, it is important to understand how reliable those tests and therefore the results you are obtaining are. By using samples of known disease status, values such as sensitivity and specificity can be calculated that allow you to evaluate just that.

READ MORE

A Further Dimension to Drug Discovery: Combining 3D Culture With iPSCs

Article

Running in parallel with advances in 3D cell culture is the growing use of human cells derived from induced pluripotent stem cells. Researchers are interested in testing drugs in the most physiologically relevant models possible, so it was only a matter of time before these two approaches converged – providing optimized systems for disease modeling and drug toxicity testing.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE